DFINE Management Team
Chief Executive Officer
Prior to joining DFINE in November 2009, Kevin served as President of Nobel Biocare's North American division. During his tenure at Nobel Biocare, Kevin helped build and grow an organization known for its stellar sales execution and consistent profitability. He was a member of the Executive Committee since joining in 2004, and helped guide the organization through several acquisitions while more than doubling the North American division's organic revenues to over $300 million. Kevin has distinguished himself as a builder of businesses that consistently exceed their executional goals. Prior to his position at Nobel Biocare, he served as President of medical device manufacturer Masimo Corporation, and spent over 11 years rising through the sales and marketing ranks at medical device stalwarts such as Baxter Healthcare and Johnson & Johnson. Mosher holds an Applied Engineering degree from the U.S. Naval Academy.
Chief Financial Officer
Lewis has over 25 years of experience in finance and operations spanning industries from high tech to medical devices. Before joining DFINE, Lewis was the head of finance for 9 years at Nobel Biocare Holdings USA, Inc with full responsibility for Accounting, Controlling, Treasury and Tax management for their North American region. Prior to Nobel, Lewis spent 11 years working for Molex, Inc, a Global Fortune 500 corporation, first as the financial controller in the UK before transferring as a member of the senior management team to a newly acquired manufacturing company located in Orange County, CA. Lewis, a member of the Australian Society of CPA’s, began his career in finance with Mobile Oil of Australia and received his Bachelor of Business with Distinction from Footscray Institue of Technology, Melbourne Australia.
Douglas M. Petty
Vice President of Marketing
Doug has over 25 years of sales and marketing experience in the medical device industry. Most recently, he was VP of Global Marketing at Thoratec Corporation, a leader in cardiovascular devices for advanced heart failure. During his time at Thoratec he built a world class marketing organization responsible for the successful worldwide launch of the Heartmate II LVAS platform which helped drive the firm's revenue to over $280M. Previously, Doug was VP of Global Marketing for Electrophysiology and Cardiovascular Imaging at Boston Scientific where he helped grow the division's revenue to over $130M along with leading key technology and business development initiatives. He also served as Director of Global Sales and Marketing for VNUS Medical Technologies. As one of the original members of the executive team, he helped to successfully create the market for minimally invasive treatment of venous disease, which led to a successful IPO and subsequent acquisition by Covidien. He has also held executive marketing positions at Vitaphore, EP Technologies and Medical Innovations. Doug is a graduate of the University of Illinois' School of Business Administration.
Robert D. Poser, D.V. M.
Vice President of Scientific and Medical Affairs
Dr. Poser has over 20 years of experience in medical device development at Baylor College of Medicine, Harrington Arthritis Research Center, Norian Corporation and Corazon Technologies. Following completion of his D.V.M. at the University of Georgia and postdoctoral clinical training, Dr. Poser completed a non-clinical fellowship in orthopedic surgery and science with a focus on biomaterials, implant design, periprosthetic bone remodeling and device product development. Upon completing his fellowship Dr. Poser was appointed Head of the Experimental Surgery at the Harrington Arthritis Research Center. Recruited to industry, he joined Norian Corporation and served as Vice President of Research and Development, directing innovative applied research and clinical application of novel calcium phosphate cement technology. Dr. Poser served as a consultant to the medical device industry prior to becoming Vice President of Science and Technology at Corazon Technology, developing minimally invasive biomimetic technology for preferential demineralization of calcific cardiovascular tissue. He joined DFINE as Vice President of Scientific and Medical Affairs in November, 2005. Dr. Poser is well published and holds numerous patents in the field of medical device innovation.
Vice President of Quality Assurance and Regulatory Affairs
Sandeep joined DFINE in March 2006 with over 15 years experience in the medical device industry setting up quality systems, manufacturing facilities and ensuring regulatory compliance at start-up and established companies. Mr. Saboo previously served as Director of Quality Assurance and Regulatory Compliance at Evalve (now part of Abbott Laboratories) from 2002 to 2006 where he set-up the quality systems and manufacturing facilities from the ground-up. Prior to Evalve, Mr. Saboo served as Director of Quality Assurance and Regulatory Affairs at Intella Interventional Systems, and management and engineering positions at Fox Hollow Technologies (now part of Covidien), Heartport (now part of J&J) and Medtronic where he was involved in setting-up quality systems from the ground-up to full commercial distribution. Mr. Saboo holds an M.S. in Industrial Engineering and Operations Research from the University of Massachusetts at Amherst and a B.S. in Mechanical Engineering from BIT Mesra, India.
Senior Vice President, Research and Development
Kirti has over 20 years of experience with various phases of medical device development. Most recently he served as an Executive Vice President at Microfabrica Inc. Prior to that, Kirti was a Senior Vice President of R&D for VNUS Medical Technologies Inc., a publicly traded company that developed, manufactured and sold a RF ablation catheter system to treat venous reflux disease. From 2003-2007 Kirti also served as a Senior Vice President at Cardiac Dimensions, Inc. with overall responsibility for R&D, Clinical Research, Regulatory Affairs and Quality Assurance. Cardiac Dimensions was an early stage company developing an implantable device to treat Mitral Regurgitation. From 1998-2003, Kirti was Vice President of Research & Development and Manufacturing at Vascular Architects Inc. a manufacturer of implantable devices used to treat peripheral vascular occlusive disease. Vascular Architects was acquired by LeMaitre Vascular. Between 1996 and 1998, Kirti held R&D and Manufacturing management positions at Somnus Medical, which developed a RF-based system to treat sleep apnea, snoring and other upper airway diseases. Somnus became publicly traded in 1997 and was subsequently acquired by Gyrus Medical. Prior to working at Somnus, Kirti held various R&D positions at Guided Medical Systems, Cardiac Pathways, Mallinckrodt Medical, C.R. Bard and Advanced Cardiovascular Systems (now Guidant) developing various cardiovascular catheters. Kirti holds a B.S. from Gujarat University (India), a M.S. from New Jersey Institute of Technology and an Executive M.B.A. from the University of Houston.
Vice President of Operations, Europe
Eric has over 17 years of international sales and marketing experience in the medical device, trauma and orthopedic spine markets. Prior to joining DFINE, Eric held the position of Vice President of Commercial Operations for Europe, the Middle East and Canada at Kyphon International, a company focused on restoring spinal function through minimally invasive therapies. Before Kyphon, he held the position of International Sales Manager at Tutogen Medical Germany, where he was responsible for all sales activities in Europe and the Middle East. Eric started his career as a sales representative at Abbott Germany selling medical devices and pharmaceutical products to hospitals before moving into the trauma and orthopedic markets, holding various positions with Synthes and Depuy in Germany.
Vice President, Manufacturing and Logistics
Patrick joined DFINE in 2008 and has over 12 years of experience working in medical device manufacturing and engineering at companies such as Kimberly-Clark, Stryker, Revivant Corp/Zoll Medical, and Hemosense / Inverness Medical Innovations. Patrick's work experience covers medical device companies from start-ups to large, highly established companies. While serving in various engineering and manufacturing positions, Patrick has overseen the design and implementation of new manufacturing processes and products, including management of overseas services and production facilities in Eastern Europe, China and Australia. As Director of Engineering and Manufacturing with Hemosense, he was instrumental in delivering 100% increase in production capacity that resulted in a $4.5 million savings to the company. At Revivant, the manufacturing processes he created were instrumental in Zoll Medical's decision to acquire the company. Patrick graduated from the University of Alabama with a BSEE, Magna Cum Laude, Electrical Engineering / Computer Engineering. Prior to entering college, Patrick proudly served in the Nuclear Power Program of the US Navy.
Linda M. Lechner
Corporate Compliance Officer
Linda has over 25 years of experience in finance and administration, primarily in the medical diagnostic industry. Most recently, she held the position of Chief Financial Officer/Vice President of Administration at Microgenics Corporation, a medical diagnostic company focused on developing and manufacturing diagnostic assays using multiple technologies. At Microgenics, Linda was responsible for managing the entire financial, IT and Human Resources functions of the Company as well as three subsidiaries. The company began as a start-up and throughout her eight years there, went through several mergers and acquisitions. Linda was instrumental in bringing the new companies together- from both a personnel and a systems approach. She has extensive experience not only with mergers and acquisitions, but ERP system implementations, establishing internal controls and providing reliable financial information. Prior to Microgenics, Linda was the Controller for Boehringer Mannheim. Linda holds a BS in Accounting from Rochester Institute of Technology.